Chimeric antigen receptor T cells Clinical Trials

2 actively recruiting trials across 1 location

Also known as: CAR T Cell, CAR T Cells, CAR T-cells, CAR-T, CAR-T Cell, CAR-T Cells, CAR-modified T-cells, Chimeric-antigen Receptor T-lymphocytes

Filter by location:

Other1 trial

CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS

Phase 1

Duarte, California1 trial

Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer

City of Hope Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.